State-of-the-Art Research on Histone Deacetylases (HDACs)
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Nuclei: Function, Transport and Receptors".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 102
Special Issue Editor
Interests: histone deacetylases (HDACs); DNA damage response; DNA repair; cell cycle checkpoint; E3 ligases; deubiquitinating enzymes (DUBs); lung cancer; chemoresistance; immunotherapy and cancer immunology
Special Issue Information
Dear Colleagues,
We are thrilled to present a Special Issue in Cells dedicated to the captivating realm of histone deacetylases.
Histone deacetylases (HDACs) are a class of enzymes that play an important role in the structural modification of chromosomes and the regulation of gene expression. They are related to cancer growth, differentiation and apoptosis. Histone deacetylase inhibitors are used for the targeted therapy of tumors, inhibiting cell growth and promoting cell differentiation and apoptosis. The inhibition of histone deacetylase (HDAC) has become an important approach to reverse the abnormal epigenetic changes associated with various cancers and non-cancer diseases.
We invite researchers, scholars and experts from around the world to contribute their valuable insights to this Special Issue. By presenting your work on the role and the involvement of HDAC in diseases, you have the opportunity to contribute to advancing our understanding of histone deacetylases.
We look forward to your contributions.
Dr. Xiaohong Zhang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- histone deacetylases
- cancer
- metabolism
- immunotherapy
- tumor microenvironment
- DNA damage response
- cell cycle
